Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

New therapy to treat rare form of cystic fibrosis works in unconventional way, scientists say

Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way.

29 Oct 2012

University of Kentucky to host Makenna Foundation Symposium on Pediatric Pulmonary Disease

The University of Kentucky is hosting the first annual Makenna Foundation Symposium on Pediatric Pulmonary Disease next Friday and Saturday.

20 Oct 2012

New discovery could help revolutionize antibiotic treatment of bacteria

Three Simon Fraser University scientists are among six researchers who've made a discovery that could help revolutionize antibiotic treatment of deadly bacteria.

20 Oct 2012

Premature babies from low-income families more likely to develop brain hemorrhages

Babies born prematurely to low-income parents have a disproportionately high risk for developing dangerous brain bleeds that require multiple surgeries and extensive follow-up, according to a small Johns Hopkins Children's Center study.

12 Oct 2012

Keynote speaker on reimbursement for new medicines

Delegates at the largest annual biotech industry gathering in the Asia-Pacific will hear about delays to new medical treatments because of the slow processing of government funding approvals. In many countries, governments pay at least part of the cost of medicines and treatments. However, there is growing concern that delays in funding decisions could mean fewer new medicines are developed in the future.

10 Oct 2012

Isolated fetal echogenic bowel ‘may be benign’

Results of a Dutch study show that the majority of fetuses with fetal echogenic bowel carry a good prognosis.

9 Oct 2012

New technique has potential to kill off hospital superbugs

Scientists at Queen's University Belfast have developed a new technique which has the potential to kill off hospital superbugs like Pseudomonas aeruginosa, C. difficile and MRSA.

5 Oct 2012

Stealth Therapeutics announces first implantation of Invisiport device

Stealth Therapeutics Inc. announced today that its Invisiport has been implanted in a patient for the first time.

27 Sep 2012

New understanding about functionality of CFTR protein

CFTR is an important protein that, when mutated, causes the life-threatening genetic disease cystic fibrosis. A study in The Journal of General Physiology (JGP) details how an accidental discovery has provided new understanding about CFTR functionality.

27 Sep 2012

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.

25 Sep 2012

Small fragments of keratin protein in the eye play a key role in warding off pathogens

When it comes to germ-busting power, the eyes have it, according to a discovery by University of California, Berkeley, researchers that could lead to new, inexpensive antimicrobial drugs.

25 Sep 2012

Children with mild to moderate kidney disease have carotid atherosclerosis

A federally funded study led by researchers at Johns Hopkins Children's Center has found that children with mild to moderate kidney disease have abnormally thick neck arteries, a condition known as carotid atherosclerosis, usually seen in older adults with a long history of elevated cholesterol and untreated hypertension.

21 Sep 2012

Two abnormalities associated with cystic fibrosis-related diabetes

A new University of Iowa study suggests there are two root causes of a type of diabetes associated with cystic fibrosis (CF). The findings, which already have sparked a clinical trial, may guide development of new treatments or even help prevent diabetes in patients with CF.

18 Sep 2012

UCSF-led research team targets physiological factors that lead to asthma attack

A new study that identifies ways to reduce the factors that lead to an asthma attack gives hope to asthma sufferers. A UCSF researcher and his colleagues believe they have found a way to help asthma sufferers by impeding the two most significant biological responses that lead to an asthma attack.

18 Sep 2012

Parents of sickle cell babies undercounseled

Parents of newborns with the sickle cell anemia trait are significantly less likely to receive genetic counseling than those of babies who are cystic fibrosis carriers, say researchers.

17 Sep 2012

Study examines link between SES and access to lung transplantation in adult CF patients

Adult cystic fibrosis (CF) patients of low socioeconomic status (SES) have a greater chance of not being accepted for lung transplant after undergoing initial evaluation, according to a new study.

14 Sep 2012

Parents of infants with cystic fibrosis carriers more likely to receive genetic counseling

Parents of newborns with the sickle cell anemia trait were less likely to receive genetic counseling than parents whose babies are cystic fibrosis carriers, a new study from the University of Michigan shows.

12 Sep 2012

KaloBios commences KB003 Phase 2 trial in severe asthma

KaloBios Pharmaceuticals, Inc. today announced that dosing has begun in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of KB003, the company's anti-GM-CSF Humaneered monoclonal antibody, in subjects with severe asthma uncontrolled by corticosteroids.

12 Sep 2012

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.

7 Sep 2012

Phase 1b trial validates efficacy of Pulmatrix PUR118 to treat COPD

Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, today announced top line results from a clinical study showing that the novel inhaled therapeutic, PUR118, demonstrated anti-inflammatory efficacy and was well-tolerated in two Phase 1b studies in patients with chronic obstructive pulmonary disease (COPD).

5 Sep 2012

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

New therapy to treat rare form of cystic fibrosis works in unconventional way, scientists say

University of Kentucky to host Makenna Foundation Symposium on Pediatric Pulmonary Disease

New discovery could help revolutionize antibiotic treatment of bacteria

Premature babies from low-income families more likely to develop brain hemorrhages

Keynote speaker on reimbursement for new medicines

Isolated fetal echogenic bowel ‘may be benign’

New technique has potential to kill off hospital superbugs

Stealth Therapeutics announces first implantation of Invisiport device

New understanding about functionality of CFTR protein

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

Small fragments of keratin protein in the eye play a key role in warding off pathogens

Children with mild to moderate kidney disease have carotid atherosclerosis

Two abnormalities associated with cystic fibrosis-related diabetes

UCSF-led research team targets physiological factors that lead to asthma attack

Parents of sickle cell babies undercounseled

Study examines link between SES and access to lung transplantation in adult CF patients

Parents of infants with cystic fibrosis carriers more likely to receive genetic counseling

KaloBios commences KB003 Phase 2 trial in severe asthma

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

Phase 1b trial validates efficacy of Pulmatrix PUR118 to treat COPD

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cystic Fibrosis News and Research

Latest Cystic Fibrosis News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in